- Overview
- Panels
- Why Choose
- Sample Requirements
- Demo Data
- FAQ
What is Olink Target 96?
Olink Target 96 is a protein biomarker discovery platform powered by Proximity Extension Assay (PEA) technology, which pairs specificity with ultra-sensitivity. Each panel covers 92 carefully curated proteins, giving researchers a high-resolution view of critical biological pathways.
- Low sample requirement: only 1–3 μL of plasma, serum, CSF, or other sample types
- Flexible applications: from biomarker discovery to drug development
- Validated across human and mouse models for translational research
Unlike traditional immunoassays, Olink's dual antibody binding and DNA tagging system minimizes off-target effects, delivering data you can trust.
Explore All Olink Target 96 Panels
15 focused panels – one powerful platform.
Researchers can choose from panels that address major areas of biomedical research. Each panel includes 92 validated proteins, allowing you to profile disease pathways, validate biomarkers, or assess drug response in a single experiment.
Immune & Inflammation
Oncology & Cell Biology
Cardiovascular & Metabolism
Neurology & Exploratory
Immune & Inflammation
-
Olink Target 96 Immune Response Panel - profiles immune activation pathways
-
Olink Target 96 Inflammatory Panel - targets cytokines and inflammation mediators
-
Olink Target 96 Immuno-Oncology Panel - links immune function to tumor biology
Oncology & Cell Biology
-
Olink Target 96 Oncology II Panel - core biomarkers for solid tumor studies
-
Olink Target 96 Oncology III Panel - expanded oncology protein coverage
-
Olink Target 96 Cell Regulation Panel - markers involved in cell cycle and apoptosis
Cardiovascular & Metabolism
-
Olink Target 96 Cardiometabolic Panel – connects metabolic and cardiovascular health
-
Olink Target 96 Cardiovascular II Panel – proteins relevant to heart disease research
-
Olink Target 96 Cardiovascular III Panel – advanced cardiac biomarker insights
-
Olink Target 96 Metabolism Panel – targets metabolic signaling pathways
Neurology & Exploratory
-
Olink Target 96 Neurology Panel – biomarkers for neurodegeneration and CNS studies
-
Olink Target 96 Neuro Exploratory Panel – discovery panel for novel neuro proteins
-
Olink Target 96 Organ Damage Panel – proteins indicating tissue and organ injury
-
Olink Target 96 Development Panel – exploratory panel for emerging research needs
-
Olink Target 96 Mouse Exploratory Panel – preclinical mouse-specific protein panel
Workflow of Olink Proteomics
Why Choose Olink Target 96?
When choosing a proteomics solution, you need accuracy, efficiency, and scalability. Olink Target 96 offers:
Minimal sample volume
only 1–3 μL required
Cost-efficient multiplexing
analyze 92 proteins in a single run
Ultra-sensitive detection
PEA technology reduces off-target effects
Broad applicability
validated for both human and mouse research
Whether you're validating oncology biomarkers, tracking inflammatory changes, or mapping neurological pathways, Olink Target 96 delivers robust, reproducible results.
Sample Requirements for Olink Target 96 Panels
Sample Type | Volume per Panel | Matrix / Notes | Storage Conditions |
Serum | Minimum 50 µL | Use clot activator tubes; avoid haemolysis | Store at −80 °C |
Plasma | Minimum 50 µL | EDTA-plasma or heparin plasma preferred | Store at −80 °C |
CSF (Cerebrospinal Fluid) | Minimum 50 µL | Collect under sterile conditions | Store at −80 °C |
Cell Culture Supernatant | Minimum 50–100 µL | Clarify by centrifugation to remove debris | Store at −20 °C to −80 °C |
Urine (optional) | Minimum 100 µL | Collect midstream sample, centrifuge before use | Store at −80 °C |
Other Matrices | Case-by-case | Contact us for guidance (e.g. saliva, synovial fluid, tissue homogenates) | Store at −80 °C |
Sample Handling Guidelines
- Avoid freeze–thaw cycles: More than two freeze–thaw events can affect protein stability.
- Labeling: Each tube must be clearly labeled with sample ID, matrix type, and collection date.
- Shipping: Send samples on dry ice to maintain cold chain integrity.
- Volume buffer: Provide an additional 10–15 µL to allow for QC and repeat analysis if needed.
Experience Real Olink Target 96 Data
To help you evaluate the platform's performance, we present actual demo results from an Olink Target 96 run:
- Volcano plots: highlight significantly changed proteins post-treatment vs. control (Panel B).
- Heatmaps: display protein expression across sample groups, clustered by expression pattern.
- Scatter charts: show reproducibility of assay duplicates for critical biomarker proteins (Panel A).
These visualizations reflect:
- Robust NPX-based relative quantification
- Minimal technical variation across replicates
- Clear protein expression trends across experimental groups

How to Explore the Demo Visuals
Data Visualization | What It Shows | Research Value |
Volcano Plot | Up/down-regulated proteins vs. statistical significance | Identify target hits for follow-up |
Heatmap | Expression clusters across samples | Explore group-specific protein signatures |
Scatter Plot | Correlation between replicate measurements | Confirms data reliability and QC consistency |
Note: Arrays include internal and external controls for run quality.
FAQ – Everything You Should Know About Olink Target 96
Q1: What sample types are compatible with Olink Target 96?
Q2: How many samples can be analyzed per Target 96 kit?
Q3: Is the data quantification absolute or relative? What is NPX?
Q4: What controls and QC measures are built into Olink Target 96?
Each plate includes internal controls for quality:
- Incubation Controls monitor antibody binding steps
- Extension & Amplification Controls help normalize across plates
A sample fails QC if control deviations exceed ± 0.3 NPX. If more than 1/6 samples per plate are flagged, the entire run is flagged for review or rerun.
Q5: What assay sensitivity and dynamic range can I expect?
Q6: How reproducible are the measurements?
Q7: Can data from different study batches or panels be compared across runs?
Use intensity normalization for randomized studies
Include 8–16 bridging samples when comparing non-randomised or multi-batch studies
This helps reduce batch effects and support robust longitudinal or cross-panel analyses.
Q8: What are on‑target and off‑target effects, and how does Olink reduce them?
Q9: Does Olink offer panels for research in mouse or rat models?
Q10: Can I use official human panels for non-human species like mouse?
Q11: What is the turnaround time from sample receipt to data delivery?
Q12: How much does Olink Target 96 cost?